The Gentle Cardiac Rehabilitation Study

The Miriam Hospital33 enrolled

Overview

The purpose of this study is to develop a tai-chi based exercise program designed for patients who recently had a heart attack and do not wish, or are unable, to attend traditional cardiac rehabilitation.

We will estimate the feasibility, acceptability and safety of two different doses of the Tai Chi intervention (primary outcome). 60 patients (30 per dose arm) will be randomly assigned to a standard dose of Tai Chi (the dose used by our group in large studies of heart failure patients) or to a high dose matching the recommended frequency and duration of exercise classes in current CRs. Acceptability assessments will include surveys and focus groups to formally assess the impact of Tai Chi on facilitators and barriers to CRs in this population. We will also obtain estimates of effect sizes of each dose on accelerometry measured physical activity and on the proportion of patients achieving the current American Heart Association (AHA) recommendation for physical activity (secondary outcome). Additional outcomes will be cardiac fitness, quality of life, body weight, and sleep. In addition, we will gather exploratory information on possible mechanisms by which Tai Chi training may affect physical activity. We will collect information on possible mediators such as exercise self-efficacy, perceived social support, and depression. In addition, since Tai Chi training is associated with meditative practices aimed at increasing present-moment awareness, we will gather information on mindfulness levels. Measurements will be conducted at baseline, 3-, 6-, and 9 months after enrollment.

Study Type

INTERVENTIONAL

Allocation

RANDOMIZED

Purpose

TREATMENT

Masking

SINGLE

Enrollment

Conditions

Secondary Prevention of Coronary Heart Disease

Interventions

PLUSBEHAVIORAL

1 hour tai chi session 3 times a week (weeks 1-12), to twice a week (week 13-16), and every other week (week 17-26) for a total of 24 weeks

LITEBEHAVIORAL

1 hour tai chi session 3 times a week (weeks 1-12)

Eligibility

Sex: ALLMin age: 21 YearsMax age: 90 Years

Medical Language ↔ Plain English

Inclusion Criteria: 1. Able to understand and speak English 2. Age ≥21 3. Physically inactive 4. Ability to understand the study procedures and willingness to commit to the demands of the study protocol Exclusion Criteria: 1. Inability or unwillingness to give informed consent 2. Planning to move out of the area within the study period 3. Unstable angina 4. Blood pressure \>200/110 or symptomatic orthostatic blood pressure decrease\>20 mmHg 5. Uncontrolled atrial or ventricular arrhythmias; 3rd degree Atrio-Ventricular block 6. Pericarditis or myocarditis 7. Recent embolism/thrombophlebitis 8. Abnormal stress test without study cardiologist's clearance 9. Medical conditions likely to limit lifespan 10. NYHA functional class IV 11. Signs of cognitive impairment (BOMC \>10) 12. Orthopedic problems prohibiting Tai Chi practice 13. Ongoing Tai Chi or other mind-body training 14. Current enrollment in a CR program 15. Severe depression (HADS scores\>14) 16. Current drug or alcohol use or dependence that would interfere with adherence to study requirements.

Locations (1)

The Miriam Hospital

Providence, Rhode Island, United States

Outcomes

Primary Outcomes

retention rates

Time frame: up to 9 months since enrollment

drop-out rates

Time frame: up to 9 months since enrollment

tai chi class attendance rates

Time frame: up to 6 months since enrollment

number of participants with severe and non severe adverse events

Time frame: up to 9 months since enrollment

percentage of participants reporting intervention acceptability scores in highest quartile

Time frame: 3, 6, and 9 months since enrollment

Secondary Outcomes

Mean between-group difference in within-participant change from baseline physical activity (accelerometry counts) over time (3, 6, and 9 months from enrollment)

To estimate mean between-doses differences in physical activity (and other continuous secondary outcomes listed below), we will estimate multivariate linear mixed models for within-participant change since baseline as a function of dose group (high or low), time point (3, 6, and 9 months from enrollment, treated as a categorical variable to allow for non-linear trajectories), and their interaction. A statistically significant interaction indicates that between-group differences vary across time points.

Time frame: baseline, 3, 6, 9 months

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.